AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
BAD PARTLY REVERSES PACLITAXEL RESISTANCE IN HUMAN OVARIAN-CANCER CELLS
Authors: STROBEL T TAI YT KORSMEYER S CANNISTRA SA
Citation: T. Strobel et al., BAD PARTLY REVERSES PACLITAXEL RESISTANCE IN HUMAN OVARIAN-CANCER CELLS, Oncogene, 17(19), 1998, pp. 2419-2427
BAX PROTEIN EXPRESSION AND CLINICAL OUTCOME IN EPITHELIAL OVARIAN-CANCER
Authors: TAI YT LEE S NILOFF E WEISMAN C STROBEL T CANNISTRA SA
Citation: Yt. Tai et al., BAX PROTEIN EXPRESSION AND CLINICAL OUTCOME IN EPITHELIAL OVARIAN-CANCER, Journal of clinical oncology, 16(8), 1998, pp. 2583-2590
ENRICHMENT FOR DNA MISMATCH REPAIR-DEFICIENT CELLS DURING TREATMENT WITH CISPLATIN
Authors: FINK D NEBEL S NORRIS PS BAERGEN RN WILCZYNSKI SP COSTA MJ HAAS M CANNISTRA SA HOWELL SB
Citation: D. Fink et al., ENRICHMENT FOR DNA MISMATCH REPAIR-DEFICIENT CELLS DURING TREATMENT WITH CISPLATIN, International journal of cancer, 77(5), 1998, pp. 741-746
BAX EXPRESSION IS ASSOCIATED WITH ENHANCED INTRACELLULAR ACCUMULATIONOF PACLITAXEL - A NOVEL ROLE FOR BAX DURING CHEMOTHERAPY-INDUCED CELL-DEATH
Authors: STROBEL T KRAEFT SK CHEN LB CANNISTRA SA
Citation: T. Strobel et al., BAX EXPRESSION IS ASSOCIATED WITH ENHANCED INTRACELLULAR ACCUMULATIONOF PACLITAXEL - A NOVEL ROLE FOR BAX DURING CHEMOTHERAPY-INDUCED CELL-DEATH, Cancer research, 58(21), 1998, pp. 4776-4781
RADIATION-INDUCED APOPTOSIS IS NOT ENHANCED BY EXPRESSION OF EITHER P53 OR BAX IN SW626 OVARIAN-CANCER CELLS
Authors: STROBEL T SWANSON L KORSMEYER S CANNISTRA SA
Citation: T. Strobel et al., RADIATION-INDUCED APOPTOSIS IS NOT ENHANCED BY EXPRESSION OF EITHER P53 OR BAX IN SW626 OVARIAN-CANCER CELLS, Oncogene, 14(23), 1997, pp. 2753-2758
CANCER DEFEATED - NOT IF, BUT WHEN - INTRODUCING THE BIOLOGY OF NEOPLASIA SERIES
Authors: CANNISTRA SA
Citation: Sa. Cannistra, CANCER DEFEATED - NOT IF, BUT WHEN - INTRODUCING THE BIOLOGY OF NEOPLASIA SERIES, Journal of clinical oncology, 15(11), 1997, pp. 3297-3298
BRCA1 MUTATIONS AND SURVIVAL IN WOMEN WITH OVARIAN-CANCER
Authors: CANNISTRA SA
Citation: Sa. Cannistra, BRCA1 MUTATIONS AND SURVIVAL IN WOMEN WITH OVARIAN-CANCER, The New England journal of medicine, 336(17), 1997, pp. 1254-1254
IN-VIVO INHIBITION OF CD44 LIMITS INTRAABDOMINAL SPREAD OF A HUMAN OVARIAN-CANCER XENOGRAFT IN NUDE-MICE - A NOVEL ROLE FOR CD44 IN THE PROCESS OF PERITONEAL IMPLANTATION
Authors: STROBEL T SWANSON L CANNISTRA SA
Citation: T. Strobel et al., IN-VIVO INHIBITION OF CD44 LIMITS INTRAABDOMINAL SPREAD OF A HUMAN OVARIAN-CANCER XENOGRAFT IN NUDE-MICE - A NOVEL ROLE FOR CD44 IN THE PROCESS OF PERITONEAL IMPLANTATION, Cancer research, 57(7), 1997, pp. 1228-1232
IN-VIVO INHIBITION OF CD44 PREVENTS PERITONEAL IMPLANTATION OF OVARIAN-CANCER CELLS
Authors: CANNISTRA SA SWANSON L STROBEL T
Citation: Sa. Cannistra et al., IN-VIVO INHIBITION OF CD44 PREVENTS PERITONEAL IMPLANTATION OF OVARIAN-CANCER CELLS, Glycobiology, 6(7), 1996, pp. 4-4
ESTROGEN-RECEPTOR EXPRESSION IS A COMMON FEATURE OF OVARIAN BORDERLINE TUMORS
Authors: ABUJAWDEH GM JACOBS TW NILOFF J CANNISTRA SA
Citation: Gm. Abujawdeh et al., ESTROGEN-RECEPTOR EXPRESSION IS A COMMON FEATURE OF OVARIAN BORDERLINE TUMORS, Gynecologic oncology, 60(2), 1996, pp. 301-307
LOCATION OF BRCA1 IN HUMAN BREAST AND OVARIAN-CANCER CELLS
Authors: SCULLY R GANESAN S BROWN M DECAPRIO JA CANNISTRA SA FEUNTEUN J SCHNITT S LIVINGSTON DM
Citation: R. Scully et al., LOCATION OF BRCA1 IN HUMAN BREAST AND OVARIAN-CANCER CELLS, Science, 272(5258), 1996, pp. 123-125
MEDICAL PROGRESS - CANCER OF THE UTERINE CERVIX
Authors: CANNISTRA SA NILOFF JM
Citation: Sa. Cannistra et Jm. Niloff, MEDICAL PROGRESS - CANCER OF THE UTERINE CERVIX, The New England journal of medicine, 334(16), 1996, pp. 1030-1038
BAX ENHANCES PACLITAXEL-INDUCED APOPTOSIS THROUGH A P53-INDEPENDENT PATHWAY
Authors: STROBEL T SWANSON L KORSMEYER S CANNISTRA SA
Citation: T. Strobel et al., BAX ENHANCES PACLITAXEL-INDUCED APOPTOSIS THROUGH A P53-INDEPENDENT PATHWAY, Proceedings of the National Academy of Sciences of the United Statesof America, 93(24), 1996, pp. 14094-14099
ABSENCE OF CONSTITUTIVE EGF RECEPTOR ACTIVATION IN OVARIAN-CANCER CELL-LINES
Authors: OTTENSMEIER C SWANSON L STROBEL T DRUKER B NILOFF J CANNISTRA SA
Citation: C. Ottensmeier et al., ABSENCE OF CONSTITUTIVE EGF RECEPTOR ACTIVATION IN OVARIAN-CANCER CELL-LINES, British Journal of Cancer, 74(3), 1996, pp. 446-452
FUNCTIONAL-HETEROGENEITY OF CD44 MOLECULES IN OVARIAN-CANCER CELL-LINES
Authors: CANNISTRA SA DEFRANZO B NILOFF J OTTENSMEIER C
Citation: Sa. Cannistra et al., FUNCTIONAL-HETEROGENEITY OF CD44 MOLECULES IN OVARIAN-CANCER CELL-LINES, Clinical cancer research, 1(3), 1995, pp. 333-342
CD44 VARIANT EXPRESSION IS A COMMON FEATURE OF EPITHELIAL OVARIAN-CANCER - LACK OF ASSOCIATION WITH STANDARD PROGNOSTIC FACTORS
Authors: CANNISTRA SA ABUJAWDEH G NILOFF J STROBEL T SWANSON L ANDERSEN J OTTENSMEIER C
Citation: Sa. Cannistra et al., CD44 VARIANT EXPRESSION IS A COMMON FEATURE OF EPITHELIAL OVARIAN-CANCER - LACK OF ASSOCIATION WITH STANDARD PROGNOSTIC FACTORS, Journal of clinical oncology, 13(8), 1995, pp. 1912-1921
EXPRESSION AND FUNCTION OF BETA-1 AND ALPHA-V-BETA-3 INTEGRINS IN OVARIAN-CANCER
Authors: CANNISTRA SA OTTENSMEIER C NILOFF J ORTA B DICARLO J
Citation: Sa. Cannistra et al., EXPRESSION AND FUNCTION OF BETA-1 AND ALPHA-V-BETA-3 INTEGRINS IN OVARIAN-CANCER, Gynecologic oncology, 58(2), 1995, pp. 216-225
INTERVAL CYTOREDUCTION IN OVARIAN-CANCER
Authors: CANNISTRA SA
Citation: Sa. Cannistra, INTERVAL CYTOREDUCTION IN OVARIAN-CANCER, The New England journal of medicine, 333(4), 1995, pp. 255-255
PACLITAXEL IN OVARIAN-CANCER - HOW CAN WE MAKE IT BETTER
Authors: CANNISTRA SA
Citation: Sa. Cannistra, PACLITAXEL IN OVARIAN-CANCER - HOW CAN WE MAKE IT BETTER, Journal of clinical oncology, 12(9), 1994, pp. 1743-1744
VASCULAR CELL-ADHESION MOLECULE-1 EXPRESSED BY PERITONEAL MESOTHELIUMPARTLY MEDIATES THE BINDING OF ACTIVATED HUMAN T-LYMPHOCYTES
Authors: CANNISTRA SA OTTENSMEIER C TIDY J DEFRANZO B
Citation: Sa. Cannistra et al., VASCULAR CELL-ADHESION MOLECULE-1 EXPRESSED BY PERITONEAL MESOTHELIUMPARTLY MEDIATES THE BINDING OF ACTIVATED HUMAN T-LYMPHOCYTES, Experimental hematology, 22(10), 1994, pp. 996-1002
MEDICAL PROGRESS - CANCER OF THE OVARY (VOL 329, PG 1550, 1993)
Authors: CANNISTRA SA
Citation: Sa. Cannistra, MEDICAL PROGRESS - CANCER OF THE OVARY (VOL 329, PG 1550, 1993), The New England journal of medicine, 330(6), 1994, pp. 448-448
CANCER OF THE OVARY - REPLIES
Authors: CANNISTRA SA
Citation: Sa. Cannistra, CANCER OF THE OVARY - REPLIES, The New England journal of medicine, 330(14), 1994, pp. 1013-1014
USE OF PERIPHERAL-BLOOD PROGENITOR CELLS ABROGATES THE MYELOTOXICITY OF REPETITIVE OUTPATIENT HIGH-DOSE CARBOPLATIN AND CYCLOPHOSPHAMIDE CHEMOTHERAPY
Authors: TEPLER I CANNISTRA SA FREI E GONIN R ANDERSON KC DEMETRI G NILOFF J GOODMAN H MUNTZ H MUTO M SHEETS E ELIAS AD MAZANET R WHEELER C AYASH L SCHWARTZ G MCCAULEY M GAYNES L HARVEY S SCHNIPPER LE ANTMAN KH
Citation: I. Tepler et al., USE OF PERIPHERAL-BLOOD PROGENITOR CELLS ABROGATES THE MYELOTOXICITY OF REPETITIVE OUTPATIENT HIGH-DOSE CARBOPLATIN AND CYCLOPHOSPHAMIDE CHEMOTHERAPY, Journal of clinical oncology, 11(8), 1993, pp. 1583-1591
HEMATOLOGIC REMISSION AND CYTOGENETIC IMPROVEMENT AFTER TREATMENT OF STABLE-PHASE CHRONIC MYELOGENOUS LEUKEMIA WITH CONTINUOUS-INFUSION OF LOW-DOSE CYTARABINE
Authors: ROBERTSON MJ TANTRAVAHI R GRIFFIN JD CANELLOS GP CANNISTRA SA
Citation: Mj. Robertson et al., HEMATOLOGIC REMISSION AND CYTOGENETIC IMPROVEMENT AFTER TREATMENT OF STABLE-PHASE CHRONIC MYELOGENOUS LEUKEMIA WITH CONTINUOUS-INFUSION OF LOW-DOSE CYTARABINE, American journal of hematology, 43(2), 1993, pp. 95-102
UNTITLED
Authors: CANNISTRA SA
Citation: Sa. Cannistra, UNTITLED, Gynecologic oncology, 51(2), 1993, pp. 292-294
Risultati: 1-25 | 26-28